Neuren Pharmaceuticals (ASX:NEU): H1 Results, DAYBUE Growth and Dividend Explained

Neuren Pharmaceuticals Limited (ASX:NEU) remained in focus within the Australian healthcare sector, with shares trading at AUD 20.37, down 3.09% or AUD 0.65 at the time of writing on 28 August 2026. Investor attention follows the company’s H1 2026 financial results released on 26 …

Aditi Sarkar | 28 August 2026

Sigma Healthcare (ASX:SIG) Strengthens Pharmacy Infrastructure Through Scale, Integration and International Expansion

Sigma Healthcare Limited (ASX:SIG) remained in focus within the Australian healthcare sector, with shares trading at AUD 2.655, up 1.34% at the time of writing on 28 August 2026. The company continues to attract investor attention after reporting its first full financial year following …

Aditi Sarkar | 28 August 2026

Fisher & Paykel Healthcare (ASX:FPH) Focuses on Global Healthcare Growth Through Innovation and Manufacturing Capability

Fisher & Paykel Healthcare Corporation Limited (ASX:FPH) remained in focus within the Australian healthcare sector, with shares trading at AUD 36.60, up 0.41% at the time of writing on 28 August 2026. The company continues to attract investor attention following its FY26 results, which …

Aditi Sarkar | 28 August 2026

ResMed (ASX:RMD) Builds on Respiratory Care Momentum as New Technologies and Healthcare Demand Drive Growth

ResMed Inc (ASX:RMD) remained in focus within the Australian healthcare sector, with shares trading at AUD 32.75, up 1.11% at the time of writing on 28 August 2026. The company continues to attract investor attention following its FY26 results, which highlighted continued growth across …

Aditi Sarkar | 28 August 2026

Why This ASX Healthcare Stock Continues to Be on Investor Radar?

Pro Medicus Limited (ASX:PME) remained one of the healthcare technology stocks under investor focus, with shares trading at AUD 185.03, up 3.23% at the time of writing on 28 August 2026. The company continues to attract market attention due to its position in enterprise …

Aditi Sarkar | 28 August 2026

Ramsay Health Care (ASX:RHC): Share Performance, FY26 Results and Key Investor Focus

Ramsay Health Care Limited (ASX:RHC) remained in focus within the Australian healthcare sector, with shares trading at AUD 50.86, up 1.60% at the time of writing on 28 August 2026. The company continues to attract investor attention following its FY26 results, which highlighted improved …

Aditi Sarkar | 28 August 2026

Sonic Healthcare (ASX:SHL) Gains Attention as Diagnostics Growth Remains in Focus

Sonic Healthcare Limited (ASX:SHL) remained on investor radar within the Australian healthcare sector, with shares trading at AUD 19.99, down 0.55% at the time of writing on 28 August 2026. The company continues to attract market attention following its FY26 results, which highlighted revenue …

Aditi Sarkar | 28 August 2026

Why Investors Are Watching Cochlear (ASX:COH) After FY26 Results?

Cochlear Limited (ASX:COH) remained on investor radar within the Australian healthcare sector, with shares trading at AUD 136.40, down 0.99% at the time of writing on 28 August 2026. The company continues to attract market attention following its FY26 results, which highlighted strategic progress …

Aditi Sarkar | 28 August 2026

Ansell (ASX:ANN): Business Overview, Share Performance and FY26 Results in Focus

Ansell Limited (ASX:ANN) remained on investor radar within the Australian healthcare sector, with shares trading at AUD 40.50, up 0.52% at the time of writing on 28 August 2026. The company continues to attract market attention following its FY26 results, which highlighted improvedEarningsperformance, stronger …

Aditi Sarkar | 28 August 2026

Can Telix Pharmaceuticals (ASX:TLX) Continue Its Healthcare Growth Momentum?

Telix Pharmaceuticals Limited (ASX:TLX) remained on investor radar within the Australian healthcare sector, with shares trading at AUD 15.69, up 0.71% at the time of writing on 28 August 2026. The company continues to attract attention as investors assess its commercial growth, radiopharmaceutical pipeline …

Aditi Sarkar | 28 August 2026

Healthcare

Neuren Pharmaceuticals (ASX:NEU): H1 Results, DAYBUE Growth and Dividend Explained

Sigma Healthcare (ASX:SIG) Strengthens Pharmacy Infrastructure Through Scale, Integration and International Expansion

Fisher & Paykel Healthcare (ASX:FPH) Focuses on Global Healthcare Growth Through Innovation and Manufacturing Capability

ResMed (ASX:RMD) Builds on Respiratory Care Momentum as New Technologies and Healthcare Demand Drive Growth

Why This ASX Healthcare Stock Continues to Be on Investor Radar?

Ramsay Health Care (ASX:RHC): Share Performance, FY26 Results and Key Investor Focus

Sonic Healthcare (ASX:SHL) Gains Attention as Diagnostics Growth Remains in Focus

Why Investors Are Watching Cochlear (ASX:COH) After FY26 Results?

Ansell (ASX:ANN): Business Overview, Share Performance and FY26 Results in Focus

Can Telix Pharmaceuticals (ASX:TLX) Continue Its Healthcare Growth Momentum?

Latest News

Kaiser Reef Passes All Six Resolutions at 13 November 2026 Annual General Meeting

Otto Energy Plans 100:1 Share Consolidation, A$20 Million Capital Return and SM71 Divestiture at 2026 AGM

Papyrus Australia Applies to Quote 20 Million Ordinary Shares Issued at $0.01 on 13 November 2026

Talga Group Releases FY Q1 2027 Investor Webinar Hosted by MD Mark Thompson on 12 November 2026

Yowie Group Launches 'Yowie GO!' Chocolate and Collectible Toy Range for 2027 Australian Debut

Future Generation Global Reports October 2026 Portfolio Decline of 1.7%, Declares 4.2 Cents Fully Franked Interim Dividend